Correction to: ACG Clinical Guideline: Management of Crohn’s Disease in Adults (The American Journal of Gastroenterology, (2018), 113, 4, (481-517), 10.1038/ajg.2018.27)

Since the publication of these Guidelines, the authors have noticed an error in the text on page 15. The incorrect statement is: Since the publication of these Guidelines, the authors have noticed an error in the text on page 15. The incorrect statement is: A recent guideline has suggested minimal “therapeutic” target trough levels; infliximab ≥7.5 μg/ml, adalimumab ≥5 μg/ml, and certolizumab pegol ≥20 μg/ml (161). The corrected statement is as follows: A recent guideline has suggested minimal “therapeutic” target trough levels; infliximab ≥5 μg/ml, adalimumab ≥7.5 μg/ml, and certolizumab pegol ≥20 μg/ml (161).